Latent Tuberculosis Infection Detection Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports

The main ways to diagnose LTBI are by placing a tuberculin skin test (TST) on the forearm or by getting a TB blood test, in addition to obtaining a chest radiograph (x-ray) if either one of these tests is positive. One-third of the world's population has LTBI. The TB germs are dormant (asleep) in the body.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-1Q15416/Global_Latent_Tuberculosis_Infection_Detection_Market_Insights_Forecast_to_2029

Market Analysis and Insights: Global Latent Tuberculosis Infection Detection Market
The global Latent Tuberculosis Infection Detection market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Latent Tuberculosis Infection Detection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Latent Tuberculosis Infection Detection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Latent Tuberculosis Infection Detection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key companies of Latent Tuberculosis Infection Detection include Abbott, QIAGEN, F. Hoffmann-La Roche Ltd, Sanofi, Oxford Immunotec USA, ARKRAY, Inc. and bioMérieux SA, etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes
This report presents an overview of global market for Latent Tuberculosis Infection Detection market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Latent Tuberculosis Infection Detection, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Latent Tuberculosis Infection Detection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Latent Tuberculosis Infection Detection revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Latent Tuberculosis Infection Detection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Latent Tuberculosis Infection Detection revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, QIAGEN, F. Hoffmann-La Roche Ltd, Sanofi, Oxford Immunotec USA, ARKRAY, Inc. and bioMérieux SA, etc.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-1Q15416/Global_Latent_Tuberculosis_Infection_Detection_Market_Insights_Forecast_to_2029

Segment by Type
• Tuberculin Skin Test
• Interferon Gamma Release Assays

Segment by Application
• Diagnostic Laboratories
• Hospitals/Clinics
• Academic & Research Institutions

By Company
Abbott, QIAGEN, F. Hoffmann-La Roche Ltd, Sanofi, Oxford Immunotec USA, ARKRAY, Inc., bioMérieux SA

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-1Q15416/global-latent-tuberculosis-infection-detection

Get similar reports
1. https://reports.valuates.com/market-reports/QYRE-Auto-14D14980/global-inflammatory-infection-detection
2. https://reports.valuates.com/market-reports/QYRE-Auto-27E9632/global-trichomonas-vaginalis-nucleic-acid-detection-kit
3. https://reports.valuates.com/market-reports/QYRE-Auto-8Y15793/global-microbial-cell-free-dna-mcfdna-detection

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.